Steven C. Mayer is the former CEO of Teva Pharmaceuticals USA, one of the world’s leading generic pharmaceutical companies. The company’s mission is to play a leading role in the transformation of the U.S. health care system through its pre-eminence in the development, manufacture and marketing of generic pharmaceuticals.
He formerly served as CEO of CoGenesys Inc., a privately owned biopharmaceutical company that he co-founded in 2005. CoGenesys was acquired by Teva in 2008.
Prior to joining CoGenesys, Mr. Mayer was executive vice president and chief financial officer of Human Genome Sciences Inc. (HGS). During his tenure at HGS, he raised more than $3 billion in equity, debt and facilities financing.
He previously served as vice president and chief financial officer of GenVec Inc., an early stage gene-therapy company, and vice president and chief financial officer for TheraTech Inc., a leading drug-delivery company.
Mr. Mayer holds an MBA from Stanford University and a BA in economics from Williams College.